Tetrabenazine

🧮 Dose calculator

Huntington disease chorea · Regimen source: FDA Tetrabenazine · 2.2

• • 37.5–50 mg in three doses; max single dose 25 mg. Above 50 mg only after CYP2D6 genotyping (EM/IM: max 100 mg/day, single 37.5 mg). With strong CYP2D6 inhibitors max 50 mg. FDA Tetrabenazine · 2.2FDA Tetrabenazine · 2.3

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Tetrabenazine · 8.1

  “Risk Summary There are no adequate data on the developmental risk associated with the use of tetrabenazine in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Tetrabenazine · 8.2

  “Risk Summary There are no data on the presence of tetrabenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects of the drug on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Tetrabenazine · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Tetrabenazine · 8.5

  “The pharmacokinetics of tetrabenazine and its primary metabolites have not been formally studied in geriatric subjects.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.